Comparison
2q23 1 Microdeletion Syndrome C4304532 vs 13q12 3 Microdeletion Syndrome C4750951
Clinical comparison between 2q23 1 Microdeletion Syndrome and 13q12 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
2q23 1 Microdeletion Syndrome C4304532
A rare chromosomal disorder involving deletion of genetic material on chromosome 2. It may cause developmental delays, movement problems, and seizures. Treatment addresses individual symptoms.
13q12 3 Microdeletion Syndrome C4750951
A rare genetic condition where a small piece of chromosome 13 is missing. It can cause various developmental and medical concerns. Care is supportive and tailored to the individual's needs.
6 comparison axes
Onset
2q23 1 Microdeletion Syndrome C4304532
0-null
13q12 3 Microdeletion Syndrome C4750951
0-null
Onset patterns differ
Severity
2q23 1 Microdeletion Syndrome C4304532
severe
13q12 3 Microdeletion Syndrome C4750951
moderate
Different severity levels
Chronic
2q23 1 Microdeletion Syndrome C4304532
Chronic
13q12 3 Microdeletion Syndrome C4750951
Chronic
Differing course
Communicable
2q23 1 Microdeletion Syndrome C4304532
No
13q12 3 Microdeletion Syndrome C4750951
No
Different transmission
Body System
2q23 1 Microdeletion Syndrome C4304532
congenital
13q12 3 Microdeletion Syndrome C4750951
congenital
Same/different system
Category
2q23 1 Microdeletion Syndrome C4304532
rare-disease
13q12 3 Microdeletion Syndrome C4750951
genetic
Different category
Bottom line
2q23-1-microdeletion-syndrome-C4304532 and 13q12-3-microdeletion-syndrome-C4750951 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q23 1 Microdeletion Syndrome C4304532 | 13q12 3 Microdeletion Syndrome C4750951 | Discriminating power |
|---|---|---|---|
| Developmental delay | Described as a possible feature of 2q23.1 microdeletion. | Developmental concerns are possible but not specifically characterized. | Low |
| Movement problems | Movement problems are specifically mentioned. | Not specifically described in the supplied source. | Moderate |
| Seizures | Seizures are specifically mentioned. | Not specifically described in the supplied source. | Moderate |
When to favor each condition
Choose 2q23 1 Microdeletion Syndrome C4304532 when
Confirmed deletion involving 2q23.1
The chromosomal location establishes the named condition.
High
Developmental delay with movement problems or seizures
These features match the supplied description, but do not prove the diagnosis.
Moderate
Severe congenital presentation
The supplied severity label is severe, although individual severity varies.
Low
Choose 13q12 3 Microdeletion Syndrome C4750951 when
Confirmed deletion involving 13q12.3
The chromosomal location establishes the named condition.
High
Developmental or medical concerns without a specified pattern
The source describes varied concerns rather than a fixed symptom set.
Moderate
Moderate congenital presentation
The supplied severity label is moderate, but this is not diagnostic.
Low
How key tests differ
| Test | 2q23 1 Microdeletion Syndrome C4304532 | 13q12 3 Microdeletion Syndrome C4750951 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May identify a deletion at 2q23.1. | May identify a deletion at 13q12.3. | Location distinguishes the conditions; clinical correlation is required. |
| Neurologic assessment | May document developmental delay, movement problems, or seizures. | May document developmental or other medical concerns. | Findings support care needs but do not replace genetic confirmation. |
| Targeted symptom evaluation | Directed by reported neurologic features. | Directed by the individual's specific concerns. | No universal laboratory cutoff is established from the supplied data. |
Prognosis comparison
2q23 1 Microdeletion Syndrome C4304532
- Outcome
- A chronic congenital condition with potentially severe effects is described; exact outcomes are not established.
- Factors
- Developmental delay, movement problems, seizures, and individual support needs.
13q12 3 Microdeletion Syndrome C4750951
- Outcome
- A chronic condition with potentially moderate effects is described; exact outcomes are not established.
- Factors
- The range and severity of developmental or medical concerns.
Time frame: Lifelong course is implied, but timing and progression are not specified.
Chromosomal finding, clinical features, comorbidities, and access to supportive care.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impairment | Developmental delays are described. Developmental concerns may occur. Extent and functional impact are not quantified here. |
| Neurologic complications | Movement problems and seizures are mentioned. Specific neurologic complications are not established. Absence from the source does not exclude them. |
| Other medical concerns | Additional complications are not specified. Various medical concerns are possible. Individual evaluation is needed for both conditions. |
Patient education highlights
- HighGenetic confirmation
The named syndrome depends on the deleted chromosomal region, not symptoms alone.
- HighSupportive care
Care is individualized and addresses identified developmental, neurologic, or medical needs.
- MediumVariable presentation
Features and severity can differ; supplied labels do not predict one person's course.